All U.K. purchases and approval of vaccines actually happened under EU rules. Until the end of 2020 the U.K. was bound by EU rules and the U.K. was part of the European Medicines Agency (EMA) 2/
In todays @Telegraph @CitySamuel write about Brexit and the difference between the purchase of vaccines in the EU and the U.K. Thread 1/
All U.K. purchases and approval of vaccines actually happened under EU rules. Until the end of 2020 the U.K. was bound by EU rules and the U.K. was part of the European Medicines Agency (EMA) 2/
In the case of emergency approval the liability for the product lies with the country allowing the emergency approval. 4/
There are EU rules on that laid down in the EU product liability directive and there are also rulings by the Europan court of Justice on vaccines and liability 5/
Very few people know. But one reason mentioned during a hearing in the European Parliament this week was BiONtech/Pfizer did not want to accept the liabilty clause in the EU contract 6/
Yes it does.
If the U.K. had still been a member of the European Union it would have been politically difficult for the U.K. to break rank and pursue its own vaccine strategy 10/
More from Society
I've seen many news articles cite that "the UK variant could be the dominant strain by March". This is emphasized by @CDCDirector.
While this will likely to be the case, this should not be an automatic cause for concern. Cases could still remain contained.
Here's how: 🧵
One of @CDCgov's own models has tracked the true decline in cases quite accurately thus far.
Their projection shows that the B.1.1.7 variant will become the dominant variant in March. But interestingly... there's no fourth wave. Cases simply level out:
https://t.co/tDce0MwO61
Just because a variant becomes the dominant strain does not automatically mean we will see a repeat of Fall 2020.
Let's look at UK and South Africa, where cases have been falling for the past month, in unison with the US (albeit with tougher restrictions):
Furthermore, the claim that the "variant is doubling every 10 days" is false. It's the *proportion of the variant* that is doubling every 10 days.
If overall prevalence drops during the studied time period, the true doubling time of the variant is actually much longer 10 days.
Simple example:
Day 0: 10 variant / 100 cases -> 10% variant
Day 10: 15 variant / 75 cases -> 20% variant
Day 20: 20 variant / 50 cases -> 40% variant
1) Proportion of variant doubles every 10 days
2) Doubling time of variant is actually 20 days
3) Total cases still drop by 50%
While this will likely to be the case, this should not be an automatic cause for concern. Cases could still remain contained.
Here's how: 🧵
One of @CDCgov's own models has tracked the true decline in cases quite accurately thus far.
Their projection shows that the B.1.1.7 variant will become the dominant variant in March. But interestingly... there's no fourth wave. Cases simply level out:
https://t.co/tDce0MwO61
Just because a variant becomes the dominant strain does not automatically mean we will see a repeat of Fall 2020.
Let's look at UK and South Africa, where cases have been falling for the past month, in unison with the US (albeit with tougher restrictions):
Furthermore, the claim that the "variant is doubling every 10 days" is false. It's the *proportion of the variant* that is doubling every 10 days.
If overall prevalence drops during the studied time period, the true doubling time of the variant is actually much longer 10 days.
Simple example:
Day 0: 10 variant / 100 cases -> 10% variant
Day 10: 15 variant / 75 cases -> 20% variant
Day 20: 20 variant / 50 cases -> 40% variant
1) Proportion of variant doubles every 10 days
2) Doubling time of variant is actually 20 days
3) Total cases still drop by 50%
